Amalia Gastaldelli
Epidemiology · 2005–2022
A researcher in the Science corpus: 6 papers; trusts 2 researchers and is trusted by 0 researchers here, as inferred from the citation graph.
Subfields
- Epidemiology — 115 citations into it
- Endocrinology, Diabetes and Metabolism — 78 citations into it
- Physiology — 32 citations into it
- Pathology and Forensic Medicine — 17 citations into it
Whom Amalia Gastaldelli trusts overall
Their strongest outbound trust, strongest first, inferred from their citations.
Papers from Amalia Gastaldelli's perspective
Ordered by how strongly the researchers Amalia Gastaldelli trusts endorse each paper. Same corpus, a different order for every researcher.
- Clinical Features and Natural History of Nonalcoholic Steatosis Syndromes (Seminars in liver disease (Print))
- Nonalcoholic fatty liver, steatohepatitis, and the metabolic syndrome (Hepatology)
- Liver, muscle, and adipose tissue insulin action is directly related to intrahepatic triglyceride content in obese subjects. (Gastroenterology)
- Endothelial dysfunction and cardiovascular risk profile in nonalcoholic fatty liver disease (Hepatology)
- Obesity is associated with macrophage accumulation in adipose tissue. (Journal of Clinical Investigation)
- The prevalence and etiology of elevated aminotransferase levels in the United States (American Journal of Gastroenterology)
- Risk of cardiovascular disease in patients with nonalcoholic fatty liver disease. (New England Journal of Medicine)
- Absence of an effect of liposuction on insulin action and risk factors for coronary heart disease. (New England Journal of Medicine)
- Prevalence of Nonalcoholic Fatty Liver Disease and Its Association With Cardiovascular Disease Among Type 2 Diabetic Patients (Diabetes Care)
- Adiponectin stimulates glucose utilization and fatty-acid oxidation by activating AMP-activated protein kinase (Nature Medicine)
Their papers
- Why Does Obesity Cause Diabetes? (2022) — 750 citations
- EASL-EASD-EASO Clinical Practice Guidelines for the Management of Non-Alcoholic Fatty Liver Disease (2016) — 3,531 citations
- Non-Alcoholic Fatty Liver Disease (NAFLD) and Its Connection with Insulin Resistance, Dyslipidemia, Atherosclerosis and Coronary Heart Disease (2013) — 772 citations
- Relationship between hepatic/visceral fat and hepatic insulin resistance in nondiabetic and type 2 diabetic subjects. (2007) — 607 citations
- A placebo-controlled trial of pioglitazone in subjects with nonalcoholic steatohepatitis. (2006) — 1,769 citations
- Insulin resistance in non-diabetic patients with non-alcoholic fatty liver disease: sites and mechanisms (2005) — 750 citations